C. E. Hack

发表

Quantitative structure–activity relationships for organophosphates binding to acetylcholinesterase

Paul E. Anderson, Christopher D. Ruark, P. Robinson, 2013, Archives of Toxicology.

Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.

Harvey J Clewell, Weihsueh A Chiu, H. Clewell, 2006, Regulatory toxicology and pharmacology : RTP.

Predicting passive and active tissue:plasma partition coefficients: interindividual and interspecies variability.

Jeffery M Gearhart, Christopher D. Ruark, P. Robinson, 2014, Journal of pharmaceutical sciences.

Lipid, water, and protein composition to facilitate kinetic modeling of the auditory pathway

T. R. Sterner, D. Mattie, N. Reo, 2018, Toxicology mechanisms and methods.

C3 is Activated in Hereditary Angioedema, and C1/C1‐Inhibitor Complexes Rise During Physical Stress in Untreated Patients

T. Mollnes, C. E. Hack, E. W. Nielsen, 1995, Scandinavian journal of immunology.

Trichloroethylene Dose Response Assessment : Additional Issues Relevant for a Scientifically Credible Approach

M. Dourson, A. Parker, C. E. Hack, 2005 .

Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future

A. M. Api, N. Hewitt, R. Becker, 2021, Frontiers in Toxicology.

Quantitative Structure–Activity Relationships for Organophosphates Binding to Trypsin and Chymotrypsin

Christopher D. Ruark, P. Robinson, J. Gearhart, 2010, Journal of toxicology and environmental health. Part A.

Jet Fuel Exacerbated Noise-Induced Hearing Loss: Focus on Prediction of Central Auditory Processing Dysfunction

T. R. Sterner, P. Robinson, D. Mattie, 2017 .

Possible role of free radical altered IgG in the etiopathogenesis of rheumatoid arthritis

C. E. Hack, A. Swaak, J. Kloster, 2004, Rheumatology International.

A rabbit lung morphology model for aerosol deposition and clearance

J. Gearhart, C. E. Hack, 2016 .

Increased Systemic Activation of Neutrophils but Not Complement in Preeclampsia

V. Videm, T. Mollnes, C. E. Hack, 2001, Obstetrics and gynecology.

Correlation of disease activity with circulating immune complexes (C1QbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus

C. E. Hack, A. Swaak, J. Groenwold, 1985, Rheumatology International.

A Neoepitope‐Based Enzyme Immunoassay for Quantification of C1‐Inhibitor in Complex with C1r and C1s

T. Mollnes, C. E. Hack, H. Fure, 1997, Scandinavian journal of immunology.

Covalent cross-links in oxygen free radical altered human immunoglobulin G.

A. Swaak, C. E. Hack, H. G. van Eijk, 1988, Scandinavian journal of rheumatology. Supplement.

Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course

C. E. Hack, A. Swaak, A. Rooyen, 2004, Rheumatology International.

Interactions between oxygen free radicals and proteins. Implications for rheumatoid arthritis. An overview.

A. Swaak, C. E. Hack, J. Koster, 1989, Scandinavian journal of rheumatology.

Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons.

John D Lambris, F. Bowen, L. Edmunds, 2000, Clinical immunology.

Acquired angio-oedema caused by IgA paraprotein.

D. V. van Spronsen, C. E. Hack, S. Hoorntje, 1998, The Netherlands journal of medicine.

Low molecular weight C1q in systemic lupus erythematosus.

R. Hoekzema, C. E. Hack, A. Hannema, 1985, Journal of immunology.

Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo.

E. Fosse, T. Mollnes, C. E. Hack, 1997, The Annals of thoracic surgery.

High C1q levels, low C1s/C1q ratios, and high levels of circulating immune complexes in kala-azar.

C. E. Hack, A. von dem Borne, P. Kager, 1982, Clinical immunology and immunopathology.

Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.

Harvey J Clewell, Dale J Marino, P Robinan Gentry, 2006, Regulatory toxicology and pharmacology : RTP.

A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.

T. Out, A. Eerenberg-Belmer, R. Aalberse, 1981, Journal of immunology.

Activation of the Complement, Coagulation, Fibrinolytic and Kallikrein–Kinin Systems During Attacks of Hereditary Angioedema

T. Mollnes, C. E. Hack, W. Wuillemin, 1996, Immunopharmacology.

Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.

T. Mollnes, C. E. Hack, E. W. Nielsen, 1996, Scandinavian journal of immunology.

Quantitative Structure-Activity Relationships for Organophosphate Enzyme Inhibition

Christopher D. Ruark, P. Robinson, J. Gearhart, 2012 .

An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion.

Harvey J Clewell, Andrew Maier, P Robinan Gentry, 2002, Toxicological sciences : an official journal of the Society of Toxicology.

SLE like syndrome and functional deficiency of C1q in members of a large family.

A. Eerenberg-Belmer, C. E. Hack, J. Kluin-Nelemans, 1984, Clinical and experimental immunology.

A Bayesian Network Model for Biomarker‐Based Dose Response

Andrew Maier, Lynne T Haber, C Eric Hack, 2010, Risk analysis : an official publication of the Society for Risk Analysis.

A Method for Biomarker Validation and Biomarker-Based Dose Response : A Case Study with a Bayesian Network Model for Benzene

W. G. Lotz, B. Fowler, P. Schulte, 2006 .

A Pharmacokinetic Model of the Intracellular Dosimetry of Inhaled Nickel

H. Clewell, J. Yager, T. Covington, 2007, Journal of toxicology and environmental health. Part A.

Significance of low molecular weight C1q in systemic lupus erythematosus.

R. Hoekzema, C. E. Hack, A. Swaak, 1990, Annals of the rheumatic diseases.

PBPK model reporting template for chemical risk assessment applications

Yu-Mei Tan, Alicia Paini, Annie Lumen, 2020, Regulatory toxicology and pharmacology : RTP.

Differential stimulation by oxygen-free-radical-altered immunoglobulin G of the production of superoxide and hydrogen peroxide by human polymorphonuclear leucocytes.

W. Sluiter, A. Swaak, C. E. Hack, 1991, Clinical science.

Mathematical Model of HIF-1 alpha Pathway, Oxygen Transport and Hypoxia

P. Robinson, D. Mattie, E. Merrill, 2017 .

Quantitative structure–activity relationships for organophosphates binding to acetylcholinesterase

Paul E. Anderson, Christopher D. Ruark, P. Robinson, 2013, Archives of Toxicology.

Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.

C Eric Hack, C. E. Hack, 2006, Toxicology.

Physiologically based pharmacokinetic modeling software

Andreas Schepky, Harvey J. Clewell, C. E. Hack, 2020 .

C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.

L. Trouw, R. Nieuwland, C. E. Hack, 2010, Clinical immunology.